Akamis Bio
Akamis Bio is a clinical-stage oncology company that develops Tumor-Specific Immuno-Gene (T-SIGn®) therapeutics aimed at enabling the immune system to target and eliminate solid tumors.
- Clinical trials for cancer treatment
- Immuno-stimulatory tumor gene therapy
- Tumor-Specific Immuno-Gene (T-SIGn®) therapeutics
Locations
Company Details
Akamis Bio is operated by Akamis Bio Limited and is a Active company incorporated on 17 November 2006 with the registered office located in Sandwich, Kent. Akamis Bio Limited was registered 19 years ago.
Status
Active
Size
Small
Directors
2
Age
19 years old
Employees
30
Turnover
£13.31M
Total Assets
£28.84M
Cash in Bank
£13.38M
Total Liabilities
-£18.17M